![]() |
市場調查報告書
商品編碼
1881338
全球製氧機市場:依類型、形式、技術、應用和地區劃分 - 市場規模、行業趨勢、機會分析和預測(2025-2033 年)Global Oxygen Generator Market: By Type, Form, Technology, Application, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033 |
||||||
全球製氧機市場是一個規模龐大且快速成長的產業,預計收入將從 2024 年的 18.622 億美元成長到 2033 年的 29.138 億美元。這意味著在 2025 年至 2033 年的預測期內,複合年增長率 (CAGR) 為 5.1%。這一成長主要受醫療和工業領域對制氧機需求不斷增長的驅動。
除了醫療和工業領域的需求外,全球醫療保健基礎設施的擴張,包括對醫療設施和技術的大量投資,也支撐著市場的發展。此外,水產養殖業也已成為一個重要的貢獻者,制氧機被用於維持魚場和水生環境中的最佳氧氣水平,從而提高生產力和永續性。這些多元化的因素共同凸顯了全球製氧機市場的動態性和多面性,預計未來幾年該市場將持續成長。
制氧機市場擁有眾多主要競爭對手,包括阿特拉斯·科普柯 (Atlas Copco)、飛利浦偉康 (Philips Respironics) 和瑞思邁 (ResMed) 等行業領導者。這些公司憑藉著豐富的產品組合、技術創新和全球分銷網絡,奠定了堅實的基礎。為了進一步鞏固市場地位,這些公司正積極尋求整合,包括併購,以擴大自身能力、提高市場佔有率並進入新的區隔市場。
除了傳統醫用製氧技術的進步外,與氧氣技術相關的領域也不斷湧現創新。一個值得關注的例子是捷途宗恆 G700 PHEV,該車型於 2025 年 10 月推出。這是一款配備外置制氧機的插電式混合動力電動車。這款車擁有令人印象深刻的 1400 公里續航里程、強勁的 892 馬力發動機,以及極具競爭力的約 46,300 美元的售價。將氧氣發生技術應用於汽車領域,標誌著跨產業創新趨勢的興起。
主要成長因素
推動醫用氧氣產生器市場成長的關鍵因素之一是高壓氧療法 (HBOT) 的快速普及。這種特殊療法透過在高於大氣壓力的環境下輸送高純度氧氣來促進康復和治療各種疾病,從而對可靠的氧氣輸送系統產生了巨大的需求。預計僅在 2024 年,美國就將新增 150 家獨立的高壓氧治療診所,反映出該療法的認可度和普及程度不斷提高。高壓氧治療對氧氣的需求尤其強勁。例如,到 2025 年,平均每次單艙高壓氧療程將消耗約 7,000 公升氧氣,這凸顯了可靠的現場製氧系統的重要性。
新興成長機會
獸醫保健產業是製氧機市場一個極具發展潛力的領域。隨著獸醫院和診所的日益完善,專業現場製氧系統的應用也日益增加。這些系統在關鍵應用中發揮著至關重要的作用,例如在外科手術中提供麻醉,以及在小型動物重症監護室中維持生命維持。獸醫護理的日益複雜化以及對高品質護理的日益重視,正在推動這一專業領域對可靠且高效的氧氣供應解決方案的需求。
優化障礙
預計在預測期內,醫用製氧機的高昂成本將對制氧機市場的成長構成重大挑戰。這些設備對於可靠、持續的氧氣供應至關重要,但通常需要大量的初始投資和維護成本。為確保安全高效的氧氣供應,所需的先進技術、精密工程和高品質材料都推高了總成本,使得一些醫療機構和患者,尤其是在對成本較為敏感的地區,難以負擔這些氧氣發生器。這種財務障礙可能會限制產品的普及率,尤其是在醫療預算有限、成本效益至關重要的新興市場。
The global oxygen generator market represents a substantial and rapidly expanding industry, with revenues projected to grow from US$ 1,862.2 million in 2024 to an impressive US$ 2,913.8 million by 2033. This growth corresponds to a compound annual growth rate (CAGR) of 5.1% over the forecast period spanning 2025 to 2033. The primary forces fueling this expansion stem from the increasing demand for oxygen generators across both medical and industrial applications.
In addition to healthcare and industrial demand, the market is also supported by expanding healthcare infrastructure worldwide, reflecting broader investments in medical facilities and technologies. Furthermore, the aquaculture industry is emerging as a noteworthy contributor, as oxygen generators are increasingly utilized to maintain optimal oxygen levels in fish farms and aquatic environments, enhancing productivity and sustainability. Together, these diverse factors underscore the dynamic and multifaceted nature of the global oxygen generator market, positioning it for sustained growth in the coming year.
The oxygen generator market features several key competitive players, including industry leaders such as Atlas Copco, Philips Respironics, and ResMed. These companies have established strong footholds through extensive product portfolios, technological innovation, and global distribution networks. To further solidify their market positions, these players are actively engaging in consolidation efforts, including mergers and acquisitions, which allow them to expand capabilities, increase market share, and enter new segments.
In addition to developments within traditional medical oxygen generation, the market is witnessing innovations in related sectors that intersect with oxygen technology. A notable example is the October 2025 introduction of the Jetour Zongheng G700 PHEV, a plug-in hybrid electric vehicle equipped with an external oxygen generator. This vehicle boasts an impressive driving range of 1,400 kilometers and a powerful 892-horsepower engine, all offered at a competitive price of approximately 46,300 USD. The integration of oxygen generation technology into automotive applications signals a broader trend of cross-industry innovation.
Core Growth Drivers
A significant factor driving the growth of the medical oxygen generator market is the rapid expansion of Hyperbaric Oxygen Therapy (HBOT). This specialized treatment, which involves delivering pure oxygen at higher-than-atmospheric pressures to promote healing and treat various medical conditions, has generated substantial demand for reliable oxygen supply systems. In 2024 alone, the United States saw the opening of 150 new standalone HBOT clinics, reflecting the therapy's growing acceptance and popularity. The oxygen requirements for HBOT are notably high; for example, an average monoplace HBOT session in 2025 consumes approximately 7,000 liters of oxygen, underscoring the critical need for dependable on-site oxygen generation.
Emerging Opportunity Trends
A promising area of growth in the oxygen generator market lies within the veterinary care sector. As veterinary hospitals and clinics become more advanced, there is a growing trend toward the adoption of on-site oxygen generation systems tailored specifically for animal healthcare. These systems play an essential role in critical applications such as delivering anesthesia during surgical procedures and providing life support in intensive care units for small animals. The increasing complexity of veterinary treatments and the rising emphasis on high-quality care are driving demand for reliable and efficient oxygen supply solutions within this specialized field.
Barriers to Optimization
The high cost associated with medical oxygen generators is anticipated to pose a significant challenge to the growth of the oxygen generator market during the forecast period. These devices, while essential for providing reliable and continuous oxygen supply, often involve substantial initial investment and maintenance expenses. The advanced technology, precision engineering, and quality materials required to ensure safe and efficient oxygen delivery contribute to the overall cost, making these generators less accessible for some healthcare providers and patients, particularly in cost-sensitive regions. This financial barrier can limit adoption rates, especially in emerging markets where healthcare budgets are constrained and cost-effectiveness is a critical consideration.
By Type, the small Pressure Swing Adsorption (PSA) oxygen generator segment is projected to capture the highest revenue share within the oxygen generator market. This segment's dominance is underpinned by its widespread adoption and proven reliability across diverse applications and industries. By 2024, over 650,000 PSA units will have been installed globally, demonstrating the technology's extensive reach and acceptance. The versatility and efficiency of small PSA oxygen generators make them particularly appealing for a range of settings, from healthcare facilities to industrial uses, where a consistent and cost-effective oxygen supply is essential.
By Form, the portable oxygen generators segment has secured the largest share in the global oxygen generator market, reflecting a strong alignment with patient needs for enhanced mobility and improved quality of life. This segment's prominence is driven by the increasing desire among individuals requiring oxygen therapy to maintain an active lifestyle without being tethered to bulky, stationary equipment.
By Application, the home-use oxygen segment holds the largest share in the global oxygen generator market. This dominance is primarily due to the rising number of patients worldwide who require long-term oxygen therapy. The shift towards home healthcare is driven by patient preference for comfort, cost-effectiveness, and the increasing availability of portable and user-friendly oxygen generation technologies.
By Type
By Form
By Technology
By Application
By Region
Geography Breakdown